[NCEZID] Risk factors, clinical course, presence and persistence of virus in various bodily fluids, and risk of sexual transmission among U.S. adults with Oropouche virus disease
[NCEZID] Risk factors,
clinical course, presence and persistence of virus in various
bodily fluids, and risk of sexual transmission among U.S. adults
with Oropouche virus disease
Reinstatement without change of a previously approved
collection
No
Regular
06/26/2025
Requested
Previously Approved
36 Months From Approved
2,850
0
663
0
0
0
Beginning in late 2023, Oropouche
virus was identified as the cause of multiple outbreaks with over
10,000 cases from 6 countries reported in 2024 as of October 15.
With these outbreaks, the virus was reported to cause disease cases
in new non-endemic areas, result in the first reported deaths, be
associated with fetal demise and congenital anomalies, and be found
in the semen of an infected traveler. Although local transmission
of the virus has not been detected yet in the United States, the
vectors capable of transmitting the virus are present in many
states and at least 90 cases of U.S. travelers returning to the
United States while infected with the virus have been reported. All
of these findings and factors, raise concerns about the broader
threat this virus represents to the United States. There are
numerous gaps in our understanding of this emerging virus,
including the urgent need to evaluate the possibility of sexual
transmission to inform prevention recommendations, especially for
pregnant people and their partners, or those considering pregnancy.
This re-instatement is submitted for the Initial Clinical and
Social Survey, Contract Tracing Survey, and Sexual Contact
Interview forms. The purpose of this change is to address feedback
from state partners and streamline the data collection by providing
clarifying language regarding the timeframes of interest for both
individuals who consent to participate and staff conducting the
interviews. There is no change to the overall burden hours
previously approved for the 0920-1446 data collection.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Form 0920-25AU Sexual Contact Interview form
Attachment_11_Consent_sexual_interview.docx
Att. 13 Privacy Impact Assessment-2.pdf
Sexual Contact Interview form